LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4561 | 5667 | 0.8048 | 0.7415 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5118 | 5667 | 0.9030 | 0.8715 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3675 | 5667 | 0.6485 | 0.5343 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5983 | 5667 | 1.0557 | 1.0737 |
MCF7 | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4161 | 5667 | 0.7342 | 0.6479 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3786 | 5667 | 0.6680 | 0.5602 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4859 | 5667 | 0.8574 | 0.8111 |
MCF7 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6186 | 5667 | 1.0915 | 1.1212 |
MCF7 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5459 | 5667 | 0.9633 | 0.9513 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4291 | 5667 | 0.7571 | 0.6782 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1389 | 1654 | 5667 | 0.2918 | 0.0619 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1526 | 5667 | 0.2692 | 0.0320 |
MCF7 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4071 | 5667 | 0.7183 | 0.6268 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3737 | 5667 | 0.6593 | 0.5487 |
MCF7 | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6100 | 5667 | 1.0762 | 1.1010 |
MCF7 | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5303 | 5667 | 0.9357 | 0.9148 |
MCF7 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6255 | 5667 | 1.1037 | 1.1373 |
MCF7 | Dactolisib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 2132 | 5667 | 0.3762 | 0.1736 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4311 | 5667 | 0.7606 | 0.6829 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4400 | 5667 | 0.7764 | 0.7038 |
MCF7 | PD0325901 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3848 | 5667 | 0.6789 | 0.5747 |
MCF7 | PD0325901 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3622 | 5667 | 0.6391 | 0.5219 |
MCF7 | PD173074 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6234 | 5667 | 1.0999 | 1.1323 |
MCF7 | PD184352 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6167 | 5667 | 1.0881 | 1.1168 |
MCF7 | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5916 | 5667 | 1.0439 | 1.0581 |